Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
26 Dezembro 2023 - 2:05PM
Edgar (US Regulatory)
Registration No. 333-260471
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Minerva Surgical, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
Delaware |
|
26-3422906 |
(State or other jurisdiction of incorporation) |
|
(I.R.S. Employer Identification No.) |
|
|
|
|
4255 Burton Dr., Santa Clara, CA |
95054 |
(Address of principal executive offices) |
(Zip Code) |
|
Minerva Surgical, Inc. 2008 Stock Plan Minerva Surgical, Inc. 2021 Equity Incentive Plan Minerva Surgical, Inc. 2021 Employee Stock Purchase Plan |
(Full title of the plan) |
|
|
Todd Usen |
Copies to: |
President and Chief Executive Officer |
Joseph Wolfson |
Minerva Surgical, Inc. |
Sunjeet S. Gill |
4255 Burton Dr. |
Stevens & Lee, P.C. |
Santa Clara, CA 95054 |
1500 Market Street, East Tower |
(855) 646-7874 |
Philadelphia, PA 19102 |
(Name, address and telephone number, including area code, of agent for service) |
(215) 575-0100 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
Large accelerated filer ◻ |
Accelerated filer ◻ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
Emerging growth company ☒ |
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
This Registration Statement shall become effective upon filing in accordance with Rule 464 promulgated under the Securities Act of 1933, as amended.
DEREGISTRATION OF SHARES
The class of securities to which this Registration Statement on Form S-8 (File No. 333-260471) (the “Registration Statement”) relates is held by fewer than 300 shareholders of record. Minerva Surgical, Inc. (the “Company”) is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister all of the shares of common stock, $0.001 par value, of the Company, and related stock options therefor, registered under the Registration Statement that remain unissued under each of the Minerva Surgical, Inc. 2008 Stock Plan, the Minerva Surgical, Inc. 2021 Equity Incentive Plan and the Minerva Surgical, Inc. 2021 Employee Stock Purchase Plan.
SIGNATURES
The Registrant. Pursuant to the requirements of the Securities Exchange Act of 1933, as amended, the Registrant certifies that is has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Clara, State of California, on December 26, 2023.
|
|
|
|
|
MINERVA SURGICAL, INC. |
|
|
|
|
|
|
Date: December 26, 2023 |
/s/ Todd Usen |
|
Todd Usen |
|
President and Chief Executive Officer |
|
(Duly Authorized Representative) |
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons in the capacities and on the date indicated.
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Uri Geiger |
|
By: |
/s/ Todd Usen |
|
Uri Geiger |
|
|
Todd Usen |
|
Chairman of the Board of Directors |
|
|
President and Chief Executive Officer |
|
|
|
|
Director |
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
Date: December 26, 2023 |
|
Date: December 26, 2023 |
|
|
|
|
|
By: |
/s/ Joel Jung |
|
By: |
/s/ Ali Behbahani |
|
Joel Jung |
|
|
Ali Behbahani |
|
Chief Financial Officer |
|
|
Director |
|
(Principal Financial and Accounting Officer) |
|
|
|
|
|
|
|
|
Date: December 26, 2023 |
|
Date: December 26, 2023 |
|
|
|
|
|
By: |
/s/ Daniel Cohen |
|
By: |
/s/ Catherine Coste |
|
Daniel Cohen |
|
|
Catherine Coste |
|
Director |
|
|
Director |
|
|
|
|
|
Date: December 26, 2023 |
|
Date: December 26, 2023 |
|
|
|
|
|
By: |
/s/ Niquette Hunt |
|
By: |
/s/ Derrick Sung |
|
Niquette Hunt |
|
|
Derrick Sung |
|
Director |
|
|
Director |
|
|
|
|
|
Date: December 26, 2023 |
|
Date: December 26, 2023 |
Minerva Surgical (NASDAQ:UTRS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Minerva Surgical (NASDAQ:UTRS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024